These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32997500)

  • 1. Protease Inhibition Mechanism of Camelid-like Synthetic Human Antibodies.
    Nam DH; Lee KB; Kruchowy E; Pham H; Ge X
    Biochemistry; 2020 Oct; 59(40):3802-3812. PubMed ID: 32997500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries.
    Nam DH; Rodriguez C; Remacle AG; Strongin AY; Ge X
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):14970-14975. PubMed ID: 27965386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.
    Remacle AG; Cieplak P; Nam DH; Shiryaev SA; Ge X; Strongin AY
    Oncotarget; 2017 Jan; 8(2):2781-2799. PubMed ID: 27835863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing proteolytic liability of a MMP-14 inhibitory antibody by site-saturation mutagenesis.
    Lee KB; Dunn Z; Ge X
    Protein Sci; 2019 Mar; 28(3):643-653. PubMed ID: 30592555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of highly selective MMP-14 inhibitory Fabs by deep sequencing.
    Lopez T; Nam DH; Kaihara E; Mustafa Z; Ge X
    Biotechnol Bioeng; 2017 Jun; 114(6):1140-1150. PubMed ID: 28090632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Highly Selective MMP Antibody Inhibitors.
    Nam DH; Ge X
    Methods Mol Biol; 2018; 1731():307-324. PubMed ID: 29318563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional selection of protease inhibitory antibodies.
    Lopez T; Mustafa Z; Chen C; Lee KB; Ramirez A; Benitez C; Luo X; Ji RR; Ge X
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16314-16319. PubMed ID: 31363054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of highly selective monoclonal antibodies inhibiting a recalcitrant protease using decoy designs.
    Lee KB; Dunn ZS; Lopez T; Mustafa Z; Ge X
    Biotechnol Bioeng; 2020 Dec; 117(12):3664-3676. PubMed ID: 32716053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope-specific affinity maturation improved stability of potent protease inhibitory antibodies.
    Lopez T; Chuan C; Ramirez A; Chen KE; Lorenson MY; Benitez C; Mustafa Z; Pham H; Sanchez R; Walker AM; Ge X
    Biotechnol Bioeng; 2018 Nov; 115(11):2673-2682. PubMed ID: 30102763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity Conversion of Protease Inhibitory Antibodies.
    Lopez T; Ramirez A; Benitez C; Mustafa Z; Pham H; Sanchez R; Ge X
    Antib Ther; 2018 Sep; 1(2):55-63. PubMed ID: 30406213
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective inhibition of matrix metalloproteinase 10 (MMP10) with a single-domain antibody.
    Razai AS; Eckelman BP; Salvesen GS
    J Biol Chem; 2020 Feb; 295(8):2464-2472. PubMed ID: 31953328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization.
    Nam DH; Fang K; Rodriguez C; Lopez T; Ge X
    Protein Eng Des Sel; 2017 Feb; 30(2):113-118. PubMed ID: 27986919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition mechanism of membrane metalloprotease by an exosite-swiveling conformational antibody.
    Udi Y; Grossman M; Solomonov I; Dym O; Rozenberg H; Moreno V; Cuniasse P; Dive V; Arroyo AG; Sagi I
    Structure; 2015 Jan; 23(1):104-115. PubMed ID: 25482542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reverse binding motif that contributes to specific protease inhibition by antibodies.
    Schneider EL; Lee MS; Baharuddin A; Goetz DH; Farady CJ; Ward M; Wang CI; Craik CS
    J Mol Biol; 2012 Jan; 415(4):699-715. PubMed ID: 22154938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against metzincin targets.
    Santamaria S; de Groot R
    Br J Pharmacol; 2019 Jan; 176(1):52-66. PubMed ID: 29488211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate derived sequences act as subsite-blocking motifs in protease inhibitory antibodies.
    Choe H; Antee T; Ge X
    Protein Sci; 2023 Jul; 32(7):e4691. PubMed ID: 37278099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation.
    Fischer T; Riedl R
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31216704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibody.
    Ciferri C; Lipari MT; Liang WC; Estevez A; Hang J; Stawicki S; Wu Y; Moran P; Elliott M; Eigenbrot C; Katschke KJ; van Lookeren Campagne M; Kirchhofer D
    Biochem J; 2015 Dec; 472(2):169-81. PubMed ID: 26385991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains.
    Chen IJ; Chuang CH; Hsieh YC; Lu YC; Lin WW; Huang CC; Cheng TC; Cheng YA; Cheng KW; Wang YT; Chen FM; Cheng TL; Tzou SC
    Sci Rep; 2017 Sep; 7(1):11587. PubMed ID: 28912497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Protease Inhibitory Antibodies by Functional In Vivo Selection.
    Lee KB; Ge X
    Methods Mol Biol; 2024; 2747():243-256. PubMed ID: 38038945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.